EPRX
Price
$5.81
Change
-$0.49 (-7.78%)
Updated
Jul 24 closing price
Capitalization
381.21M
11 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$22.21
Change
+$0.20 (+0.91%)
Updated
Jul 24 closing price
Capitalization
2.52B
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EPRX vs IMNM

EPRX vs IMNM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EPRX vs. IMNM commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a StrongBuy and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2026
Stock price -- (EPRX: $5.81 vs. IMNM: $22.21)
Brand notoriety: EPRX and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 146% vs. IMNM: 23%
Market capitalization -- EPRX: $381.21M vs. IMNM: $2.52B
EPRX [@Biotechnology] is valued at $381.21M. IMNM’s [@Biotechnology] market capitalization is $2.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • EPRX’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both EPRX and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • EPRX’s TA Score: 4 bullish, 5 bearish.
  • IMNM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а -11.84% price change this week, while IMNM (@Biotechnology) price change was -0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 07, 2026.

IMNM is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.52B) has a higher market cap than EPRX($381M). IMNM YTD gains are higher at: 3.399 vs. EPRX (-23.046). EPRX has higher annual earnings (EBITDA): -47.14M vs. IMNM (-235.83M). IMNM has more cash in the bank: 583M vs. EPRX (139M). EPRX has less debt than IMNM: EPRX (2.01M) vs IMNM (3.69M). IMNM has higher revenues than EPRX: IMNM (4.02M) vs EPRX (0).
EPRXIMNMEPRX / IMNM
Capitalization381M2.52B15%
EBITDA-47.14M-235.83M20%
Gain YTD-23.0463.399-678%
P/E RatioN/AN/A-
Revenue04.02M-
Total Cash139M583M24%
Total Debt2.01M3.69M54%
TECHNICAL ANALYSIS
Technical Analysis
EPRXIMNM
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INDL42.480.68
+1.63%
Direxion Daily MSCI India Bull 2x ETF
SPGP121.641.13
+0.94%
Invesco S&P 500 GARP ETF
BKFI23.510.01
+0.06%
BNY Mellon Active Core Bond ETF
KJAN45.54N/A
N/A
Innovator US Small Cap Pwr Buff ETF™ Jan
AMUU262.46N/A
N/A
Direxion Daily AMD Bull 2X Shares

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and LCTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and LCTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-7.78%
LCTX - EPRX
32%
Poorly correlated
-3.74%
NAGE - EPRX
32%
Poorly correlated
+0.63%
MIST - EPRX
29%
Poorly correlated
-3.33%
NTLA - EPRX
29%
Poorly correlated
-3.33%
IMNM - EPRX
29%
Poorly correlated
+0.91%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+0.91%
KURA - IMNM
49%
Loosely correlated
-0.57%
KYTX - IMNM
49%
Loosely correlated
+1.65%
NRIX - IMNM
46%
Loosely correlated
-1.52%
VYGR - IMNM
45%
Loosely correlated
+0.32%
RLAY - IMNM
45%
Loosely correlated
-3.40%
More